Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond: a position statement of the European Expert Panel for Testosterone Research

Zitzmann, M. orcid.org/0000-0003-3629-7160, Rastrelli, G. orcid.org/0000-0002-6164-4278, Murray, R.D. et al. (13 more authors) (2025) Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond: a position statement of the European Expert Panel for Testosterone Research. Andrology. ISSN 2047-2919

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2025 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/

Keywords: cardiosvascular risk; classical hypogonadism; functional hypogonadism; testosterone; testosterone therapy
Dates:
  • Submitted: 3 December 2024
  • Accepted: 29 April 2025
  • Published (online): 15 May 2025
  • Published: 15 May 2025
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Academic Unit of Medical Education (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 19 May 2025 13:52
Last Modified: 19 May 2025 13:52
Status: Published online
Publisher: Wiley
Refereed: Yes
Identification Number: 10.1111/andr.70062
Open Archives Initiative ID (OAI ID):

Export

Statistics